Evidence map›Paper›PMID 23733368›Full record

ArticleEMBO molecular medicine2013

MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways.

Henry S Cheng, Nirojini Sivachandran, Andrew Lau, Emilie Boudreau, Jimmy L Zhao, David Baltimore, Paul Delgado-Olguin, Myron I Cybulsky, Jason E Fish

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 237 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
237citing papers in PubMed, 5 pooled it
12.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

237 citing papers in PubMed, 5 syntheses or guidelines pooled it, 425 citations in OpenAlex.

  1. Role of miRNA in Cardiovascular Diseases in Children-Systematic Review.International journal of molecular sciences · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Association Between Single-Nucleotide Polymorphism (SNP) in miR-146a, miR-196a2, and miR-499 and Risk of Ischemic Stroke: A Meta-Analysis.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Pooled it
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

177 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Henry S ChengToronto General Research Institute, University Health Network, Toronto, Canada.
Nirojini Sivachandran
Andrew Lau
Emilie Boudreau
Jimmy L Zhao
David Baltimore
Paul Delgado-Olguin
Myron I Cybulsky
Jason E Fish
University of Toronto · CACalifornia Institute of Technology · USHeart and Stroke Foundation · CAHospital for Sick Children · CAUniversity Health Network · CA

Funding

UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
MicroRNA Function in the Immune SystemR01AI079243 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BALTIMORE, DAVID · 2008 to 2018
$4.1M
Investigate the function of miR-146a in myeloid developmentF30HL110691 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ZHAO, JIMMY LIU · 2011 to 2014
$185k
CIHRNHLBI NIH HHS F30 HL110691NIAID NIH HHS R01 AI079243NIGMS NIH HHS T32 GM008042
6 · The paper itself

Abstract

Activation of inflammatory pathways in the endothelium contributes to vascular diseases, including sepsis and atherosclerosis. We demonstrate that miR-146a and miR-146b are induced in endothelial cells upon exposure to pro-inflammatory cytokines. Despite the rapid transcriptional induction of the miR-146a/b loci, which is in part mediated by EGR-3, miR-146a/b induction is delayed and sustained compared to the expression of leukocyte adhesion molecules, and in fact coincides with the down-regulation of inflammatory gene expression. We demonstrate that miR-146 negatively regulates inflammation. Over-expression of miR-146a blunts endothelial activation, while knock-down of miR-146a/b in vitro or deletion of miR-146a in mice has the opposite effect. MiR-146 represses the pro-inflammatory NF-κB pathway as well as the MAP kinase pathway and downstream EGR transcription factors. Finally, we demonstrate that HuR, an RNA binding protein that promotes endothelial activation by suppressing expression of endothelial nitric oxide synthase (eNOS), is a novel miR-146 target. Thus, we uncover an important negative feedback regulatory loop that controls pro-inflammatory signalling in endothelial cells that may impact vascular inflammatory diseases.

Indexed as

Signal TransductionAnimalsCell LineCytokinesDown-RegulationELAV ProteinsEndothelial CellsEndothelium, VascularGenetic LociHumansInflammationInflammation MediatorsInterleukin-1betaMiceMice, Inbred C57BLMice, KnockoutCytokinesELAV ProteinsInflammation MediatorsInterleukin-1betaMicroRNAsMIRN146 microRNA, humanMirn146 microRNA, mouseMitogen-Activated Protein KinasesNF-kappa BTranscription Factor AP-1atherosclerosisendotheliumgene regulationinflammationmicroRNA

Identifiers

PMID23733368
PMCPMC3721471
OpenAlexW2164840475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.